The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Thankyou hopingforbags, I have read your messages on this before, you are probably right.
I actually anticipated a placing for cuda but I guessed that the process would take a good long while and the sp would be higher by then.
What I didn't anticipate was Art placing long before he would need the money!
I'm usually cautious to negative but.
At 20p a share for cuda and drilling... its a huge dilution yes, it limits the maximum this can go to, but it's at worst value neutral if we get cuda.
Shares don't always go down after placings, they do when there is a reason for them to. This is actually neutral to good news imho.
'So I would ask yourselves before you write, is what you are writing going to help the company, if the answer is NO, then don't write it.'
That never helps.
When I look to buy into a stock, as someone with limited knowledge, a balanced board with positives and negatives is a plus.
The only times ramping helps is in stocks with very low information, as in copl before it relisted.
People predicted 1-2.5p on relist. We are at 1/5th of the most modest consensus prediction.
So long term, those positive posts did not help at all. However, I very much suspect that the share would be valued higher now if those predictions had been more realistic. Ramping leads to backlash and poor sentiment in the long run. It's a facet of narrative and human nature; we don't tolerate setbacks in a nailed on 10 bagger, we quickly begin to see it as a dog.
A stock which is discussed soberly, warts and all, is going to have more people prepared to hold through the ups and downs than one which is hyped.